BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 576505)

  • 1. [Influence of radiopaque substance and concentration of contrast media as well as time of infusion on excretion of contrast medium and incidence of side effects (author's transl)].
    Schmerwitz W; Rösch E
    Rontgenblatter; 1977 Feb; 30(2):71-8. PubMed ID: 576505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Injection cholecystography--influence of radiopaque substance and injection time on the excretion of contrast media and incidence of side effects].
    Schmerwitz W
    Rontgenblatter; 1977 Feb; 30(2):64-70. PubMed ID: 576504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A contribution to the rate of side-effects of hepatotropic contrast media. A clinical comparative study of iodoxamate (Endomirabil) and ioglycamid (Bilivistan) (author's transl)].
    Kölling K; Hoenle R; Korsten FW
    Radiologe; 1977 Feb; 17(2):70-3. PubMed ID: 322198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the biliary excretion of the hepatotropic contrast media ioglycamate and iotroxinate in pigs and men (author's transl)].
    Klapdor R; Aban Y; Sepehr H; Scherer K
    Rontgenblatter; 1978 Feb; 31(2):114-9. PubMed ID: 635378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tolerance and contrast density in intravenous cholangiography and cholecystography using a new contrast medium (author's transl)].
    Siemers M; Schäfer K; Menges G; Horst H
    Rontgenblatter; 1978 Oct; 31(10):596-9. PubMed ID: 581525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experiences with iodoxamic acid in the cholecystography-cholangiography (author's transl)].
    Keiner F
    Med Klin; 1976 Oct; 71(44):1885-90. PubMed ID: 1036604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The results and tolerability of infusion cholegraphy using ioglycamide-85 (12.75 g meglumine salt in 75 ml) in comparison with the use of a hypotonic adipiodone solution (10 g meglumine salt in 100 ml)].
    Ronneburg HP
    Radiol Diagn (Berl); 1990; 31(3):253-60. PubMed ID: 2367631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quality of roentgenological visualization and tolerance of various intravenous cholegraphic contrast media (author's transl)].
    Tischendorf P
    Rontgenblatter; 1980 Nov; 33(11):581-7. PubMed ID: 7003680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experience with a new intravenous contrast medium, BC-17 in cholecystography and cholangiography (author's transl)].
    Inamoto K; Miyoshi K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1974 Oct; 34(10):725-34. PubMed ID: 4533780
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetics and plasma albumen binding of iotroxic acid (Biliscopin), iodoxic acid (Endomirabil) and ioglycamine (Biligram) (author's transl)].
    Taenzer V; Speck U; Wolf R
    Rofo; 1977 Mar; 126(3):262-7. PubMed ID: 139346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intravenous cholangio-cystography during childhood (author's transl)].
    Fahr K; Oppermann HC; Willich E
    Rofo; 1977 Jun; 126(6):571-6. PubMed ID: 142722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse reactions to intravenous cholangiography with Biligram.
    Hald JK
    Eur J Radiol; 1984 Aug; 4(3):196-7. PubMed ID: 6468411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cholangiography and cholecystography with a new water-soluble contrast medium (BC-17) by intravenous drip infusion (II). Effects on tests of thyroid function (author's transl)].
    Tanimura H; Ishii K; Fujimura M; Matsuda M
    Nihon Geka Hokan; 1974 Nov; 43(6):476-85. PubMed ID: 4480399
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new bile contrast in pediatrics (author's transl)].
    Fahr K; Oppermann HC; Willich E
    Monatsschr Kinderheilkd (1902); 1978 Jun; 126(6):391-4. PubMed ID: 661834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experiment compared between iodoxamidic acid and ioglycamic acid, in flasks drop by drop. Observations of adverse reactions].
    Viviani G; Mozzanica C; Pozzoli P
    J Radiol Electrol Med Nucl; 1975; 56 suppl 2():548. PubMed ID: 1243924
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intravenous cholangiocholecystography using ioglycamide--indications and value].
    Wujciak D; Weingärtner R; Illmann E; Baars HG
    Radiol Diagn (Berl); 1990; 31(3):247-51. PubMed ID: 2367630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern X-ray contrast media applicable to intravenous cholangiocholecystography (review of the literature)].
    Sviridov NK; Popova ZP; Varfolomeeva VN; Mikhaĭlova NA
    Farmakol Toksikol; 1981; 44(2):245-7. PubMed ID: 7023971
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dose-effects of the contrast medium Iotroxinate on biliary excretion of contrast media during infusion cholegraphy (author's transl)].
    Klapdor R
    Rofo; 1978 Aug; 129(2):215-6. PubMed ID: 151018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drip infusion cholecysto-cholangiography with iodoxamate (BC-17) (III). Especially, compared with iodipamide (author's transl)].
    Tanimura H; Takenaka M; Setoyama M; Kamata T
    Nihon Geka Hokan; 1977 May; 46(3):313-25. PubMed ID: 578092
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cholecystocholangiography via short-term infusion of iodoxamate (author's transl)].
    Maier W
    Rontgenblatter; 1981 Jan; 34(1):20-3. PubMed ID: 6894039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.